Hereditary systemic amyloidosis

Gene: APOA4

Amber List (moderate evidence)

APOA4 (apolipoprotein A4)
EnsemblGeneIds (GRCh38): ENSG00000110244
EnsemblGeneIds (GRCh37): ENSG00000110244
OMIM: 107690, Gene2Phenotype
APOA4 is in 2 panels

1 review

Ida Ertmanska (Genomics England Curator)

Green List (high evidence)

Comment on list classification: There are 5 distantly related families reported in literature with with chronic kidney disease, harbouring 2 different monoallelic missense variants. The variants segregated with disease in an autosomal dominant manner (PMID: 38096951). Other reports found that ApoA4 protein is the main component of amyloid deposits found in renal biopsies of patients with medullary amyloidosis. Similarly, ApoA4 deposits have been reported in cases of cardiac amyloidosis. However, the affected individuals did not have pathogenic APOA4 mutations, suggesting variants in other genes may also lead to ApoA4 aggregation. Based on available evidence, this gene should be promoted to Green for Hereditary systemic amyloidosis.
Created: 19 Dec 2025, 8:43 a.m. | Last Modified: 19 Dec 2025, 8:43 a.m.
Panel Version: 1.27
PMID: 38096951 Kmochova et al., 2024
3 distantly related families with (NM_000482.4):c.196C>G, p.Leu66Val, 2 distantly related families with c.97G>A, p.Asp33Asn. Method: WGS. Affected individuals presented with chronic kidney disease, with mean age of kidney failure of 64.5 years. Kidney biopsies from affected individuals showed amyloid deposits in the medulla, with Apoa4 protein being the main constituent.
p.Leu66Val - 3 heterozygotes in gnomAD v4.1.0 (European), Revel score = 0.27
p.Asp33Asn - not in gnomAD v4, though p.Asp33Glu and p.Asp33Val have been reported; Revel score = 0.31

PMID: 33751222 Murakami et al., 2021
Report of a 68 yo Japanese man, with 4 variants in APOA4: 2 synonymous (p.Thr29Thr, p.Leu128Leu); '6981A>C',p.Asn248Thr; and c.743A>C, p.Asn248Thr - not in gnomAD v4. Only APOA4 was sequenced. Patient had history of renal cysts, diagnosed with HCM 2 years prior. Authors highlight that Apoa4 protein aggregation is causal, but the gene variant may not be.

PMID: 28449784 Bois et al., 2017
13 patients with AApoAIV cardiac amyloidosis, mean age 75 years. Patients had cardiac dysfunction. Of 9 patients evaluated in detail, 8/9 had chronic kidney disease (various stages). Autopsy of 4 cases showed small vessel involvement and prominent medullary renal deposits Genetic analysis was performed, but 'did not identify definitive pathological mutations.'

PMID: 27262366 Dasari et al. 2016
Reported 11 patients with Apolipoprotein A-IV associated amyloidosis (mean age at diagnosis 63.5yrs). Biopsies showed large amounts of eosinophilic Congo–red positive amyloid deposits restricted to the renal medulla. ApoA-IV protein was the most abundant peptide in the amyloid deposits. However, molecular analysis was performed in only 2/11 patients, and no APOA4 mutations were found.

PMID: 21900878 Sethi et al., 2012
52yo man with CKD and amyloid deposits in the medulla, harbouring 3 common, likely benign APOA4 variants: c.548G>A, p.(Thr29Thr); c.1678G>A, p.(Ser147Asn); c.2378G>T, p.(Gln380His). He also carried 2 APOA1 variants: c.60T>C, p.(His20His) - synonymous, not in gnomAD; c.209T>C, p.(Leu70Pro) - missense, not in gnomAD v4. APOA1 more likely to be causal? Only sequenced these 2 genes.

Conflicting functional evidence: PMID: 39699959 Nakamura et al., 2024: TFEB downregulation in aged mice leads to APOA4 amyloidosis, though only 26.7% of mice showed 'extensive' amyloid deposition. Variants in other genes may cause APOA4 to aggregate?

APOA4 is linked to Tubulointerstitial kidney disease, autosomal dominant 6, MIM: 621106 (OMIM accessed 18th Dec 2025).
Sources: Literature
Created: 18 Dec 2025, 12:13 p.m. | Last Modified: 19 Dec 2025, 8:48 a.m.
Panel Version: 1.27

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
Tubulointerstitial kidney disease, autosomal dominant 6, OMIM: 621106; tubulointerstitial kidney disease, autosomal dominant 6, MONDO:0976234; AApoAIV amyloidosis, MONDO:0018589

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • Expert Review Amber
  • Literature
Phenotypes
  • Tubulointerstitial kidney disease, autosomal dominant 6, OMIM: 621106
  • tubulointerstitial kidney disease, autosomal dominant 6, MONDO:0976234
  • AApoAIV amyloidosis, MONDO:0018589
Tags
Q4_25_promote_green
OMIM
107690
Clinvar variants
Variants in APOA4
Penetrance
None
Publications
Panels with this gene

History Filter Activity

19 Dec 2025, Gel status: 2

Removed Tag

Ida Ertmanska (Genomics England Curator)

Tag Q4_25_NHS_review was removed from gene: APOA4.

19 Dec 2025, Gel status: 2

Added Tag, Added Tag

Ida Ertmanska (Genomics England Curator)

Tag Q4_25_promote_green tag was added to gene: APOA4. Tag Q4_25_NHS_review tag was added to gene: APOA4.

18 Dec 2025, Gel status: 2

Removed Tag

Ida Ertmanska (Genomics England Curator)

Tag Q4_25_promote_green was removed from gene: APOA4.

18 Dec 2025, Gel status: 2

Entity classified by Genomics England curator

Ida Ertmanska (Genomics England Curator)

Gene: apoa4 has been classified as Amber List (Moderate Evidence).

18 Dec 2025, Gel status: 1

Created, Added New Source, Added Tag, Set mode of inheritance, Set publications, Set Phenotypes

Ida Ertmanska (Genomics England Curator)

gene: APOA4 was added gene: APOA4 was added to Hereditary systemic amyloidosis. Sources: Literature Q4_25_promote_green tags were added to gene: APOA4. Mode of inheritance for gene: APOA4 was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown Publications for gene: APOA4 were set to 21900878; 27262366; 33751222; 38096951; 39699959 Phenotypes for gene: APOA4 were set to Tubulointerstitial kidney disease, autosomal dominant 6, OMIM: 621106; tubulointerstitial kidney disease, autosomal dominant 6, MONDO:0976234; AApoAIV amyloidosis, MONDO:0018589 Review for gene: APOA4 was set to GREEN